Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» non-small cell lung cancer
non-small cell lung cancer
Merck, Bristol-Myers cancer drugs both beat expectations, but Merck beats them a little more
CNBC
Mon, 04/16/18 - 09:46 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Yervoy
non-small cell lung cancer
AACR
We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated
San Francisco Gate, CA
Sun, 04/15/18 - 10:04 pm
lung cancer
cancer
Merck
Roche
Bristol-Myers Squibb
AACR
non-small cell lung cancer
AstraZeneca's (AZN) Imfinzi Gets FDA Nod for Label Expansion
Yahoo/Zacks.com
Mon, 02/19/18 - 11:42 am
AstraZeneca
FDA
Imfinzi
non-small cell lung cancer
AstraZeneca's Tagrisso Label Expansion Filing Accepted by FDA
Yahoo/Zacks.com
Tue, 12/19/17 - 10:24 am
AstraZeneca
Tagrisso
FDA
labeling
non-small cell lung cancer
Most Damaging Clinical Trial Failure: AstraZeneca's MYSTIC
BioPharma Dive
Mon, 12/4/17 - 09:42 pm
clinical trials
AstraZeneca
Mystic
Imfinzi
non-small cell lung cancer
Recent Developments for Merck’s Keytruda
Market Realist
Fri, 12/1/17 - 12:02 pm
Merck
Keytruda
immuno-oncology
anti-PD-1 immunotherapy
non-small cell lung cancer
AstraZeneca touts Tagrisso's CNS benefit
BioPharma Dive
Tue, 11/21/17 - 09:45 am
Tagrisso
AstraZeneca
non-small cell lung cancer
CNS metastases
Here's Why Merck & Co., Inc. Tanked 14% in October
Motley Fool
Wed, 11/8/17 - 06:20 pm
Merck
Keytruda
Europe
non-small cell lung cancer
FDA adds fresh ‘breakthrough’ for Novartis’ cancer combo Tafinlar and Mekinist
Endpoints
Mon, 10/23/17 - 09:57 am
FDA
Novartis
Tafinlar
Mekinist
non-small cell lung cancer
Hunting an early FDA OK, Ignyta surges on promising snapshot of lung cancer data
Endpoints
Wed, 10/18/17 - 09:24 am
Ignyta
entrectinib
non-small cell lung cancer
After getting skunked by rivals, Pfizer touts ‘breakthrough’ cancer drug lorlatinib, heads to the FDA
Endpoints
Mon, 10/16/17 - 12:00 pm
Pfizer
lorlatinib
FDA
non-small cell lung cancer
Lilly's lung cancer drug fails main goal of key study
Yahoo/Reuters
Tue, 10/10/17 - 09:35 am
Eli Lilly
lung cancer
clinical trials
Verzenio
non-small cell lung cancer
AbbVie pairs up another ADC cancer drug with Bristol-Myers Squibb's Opdivo
Fierce Biotech
Sat, 09/23/17 - 10:02 am
AbbVie
Bristol-Myers Squibb
Opdivo
ABBV-399
antibody-drug conjugate
non-small cell lung cancer
Merck's new Keytruda flat dose could add $1B each year to U.S. healthcare spending
Fierce Pharma
Mon, 07/17/17 - 06:49 pm
Merck
Keytruda
drug pricing
non-small cell lung cancer
FDA approves diagnostic that simultaneously screens for multiple cancer biomarkers
Drug Delivery Business News
Sat, 06/24/17 - 09:07 am
FDA
Thermofisher
diagnostics
biomarkers
non-small cell lung cancer
Oncomine Dx Target Test
Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
Fierce Pharma
Fri, 06/23/17 - 03:35 pm
Novartis
FDA
Tafinlar
Mekinist
non-small cell lung cancer
BRAF V600
Incyte keeps the ASCO spotlight focused on its closely-watched IDO1 drug epacadostat
Endpoints
Mon, 06/5/17 - 10:08 am
Incyte
ASCO 2017
epacadostat
non-small cell lung cancer
Keytruda
Novartis' Zykadia piles pressure on Pfizer's Xalkori, Roche's Alecensa with new lung cancer nod
Fierce Pharma
Wed, 05/31/17 - 09:32 am
Novartis
Zykadia
Pfizer
Xalkori
Roche
Alecensa
non-small cell lung cancer
Incyte gets a boost from a series of positive data snapshots for its epacadostat/Keytruda combo
Endpoints
Thu, 05/18/17 - 12:08 am
Incyte
epacadostat
ASCO 2017
Merck
Keytruda
non-small cell lung cancer
Syndax shares soar as lead drug clears a mid-stage cancer drug study hurdle
Endpoints
Thu, 05/18/17 - 12:02 am
Syndax Pharma
clinical trials
entinostat
non-small cell lung cancer
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »